The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology

Atherosclerosis, a chronic inflammatory disease, is driven by complex molecular mechanisms involving inflammatory cytokines and immune pathways. According to recent research, tricyclic antidepressants (TCAs), which are typically prescribed to treat depressive disorders, have strong anti-inflammatory...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Majid Eslami, Marzieh Monemi, Mohammad Ali Nazari, Mohammad Hossein Azami, Parand Shariat Rad, Valentyn Oksenych, Ramtin Naderian
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-01-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	tricyclic antidepressants (TCAs) atherosclerosis pathophysiology inflammasome cytokine
Online-Zugang:	https://www.mdpi.com/1424-8247/18/2/197
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!